Oragenics, Inc. (OGEN)
0.201
-0.15
(-42.59%)
USD |
NYAM |
Nov 13, 16:00
0.2061
+0.01
(+2.54%)
After-Hours: 19:59
Oragenics Total Assets (Quarterly) : 3.282M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 3.282M |
| June 30, 2026 | 5.492M |
| March 31, 2026 | 7.490M |
| December 31, 2025 | 10.07M |
| September 30, 2025 | 12.71M |
| June 30, 2025 | 2.140M |
| March 31, 2025 | 3.869M |
| December 31, 2024 | 1.472M |
| September 30, 2024 | 5.204M |
| June 30, 2024 | 2.710M |
| March 31, 2024 | 3.534M |
| December 31, 2023 | 4.966M |
| September 30, 2023 | 7.899M |
| June 30, 2023 | 8.464M |
| March 31, 2023 | 12.13M |
| December 31, 2022 | 14.76M |
| September 30, 2022 | 17.05M |
| June 30, 2022 | 18.47M |
| March 31, 2022 | 23.65M |
| December 31, 2021 | 28.23M |
| September 30, 2021 | 31.09M |
| June 30, 2021 | 35.25M |
| March 31, 2021 | 37.37M |
| December 31, 2020 | 18.68M |
| September 30, 2020 | 11.28M |
| Date | Value |
|---|---|
| June 30, 2020 | 10.73M |
| March 31, 2020 | 15.56M |
| December 31, 2019 | 19.75M |
| September 30, 2019 | 23.65M |
| June 30, 2019 | 26.93M |
| March 31, 2019 | 31.31M |
| December 31, 2018 | 22.05M |
| September 30, 2018 | 15.54M |
| June 30, 2018 | 5.209M |
| March 31, 2018 | 5.494M |
| December 31, 2017 | 7.215M |
| September 30, 2017 | 5.135M |
| June 30, 2017 | 4.577M |
| March 31, 2017 | 2.351M |
| December 31, 2016 | 4.340M |
| September 30, 2016 | 6.411M |
| June 30, 2016 | 8.137M |
| March 31, 2016 | 3.957M |
| December 31, 2015 | 5.778M |
| September 30, 2015 | 7.390M |
| June 30, 2015 | 8.696M |
| March 31, 2015 | 9.762M |
| December 31, 2014 | 11.13M |
| September 30, 2014 | 12.30M |
| June 30, 2014 | 13.34M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Candel Therapeutics, Inc. | 211.11M |
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 189.60M |
| Savara, Inc. | 155.93M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.189M |
| Shareholders Equity (Quarterly) | 1.092M |
| Debt to Equity Ratio | 0.363 |
| Current Ratio | 1.499 |
| Net Debt Paydown Yield | 23.46% |